Clinical Report: Amendment on Assessing Mental Wellbeing in Adolescents
Overview
This report details a correction regarding the COMPAS-W Wellbeing Scale used to assess mental wellbeing in adolescents. The proprietary nature of the scale has been clarified, and the intellectual property rights have been assigned to Tilt Your Life Pty Ltd.
Background
Mental health issues, particularly depression and anxiety, are prevalent among adolescents, contributing significantly to the global disease burden. Accurate assessment tools like the COMPAS-W Wellbeing Scale are essential for understanding and addressing these issues in youth populations.
Data Highlights
No numerical data is provided in the source material.
Key Findings
['The COMPAS-W Wellbeing Scale was validated in a sample of adolescents aged 13-17.', 'A 23-item model of the scale provided the best fit for the adolescent population.', 'The internal consistency for the total score was reported as α=0.912.', 'The intellectual property rights to the COMPAS-W scale are now held by Tilt Your Life Pty Ltd.', 'The original findings of the study remain unaffected by the recent amendment.']
Clinical Implications
Clinicians should be aware of the proprietary nature of the COMPAS-W scale and the need to contact the corresponding author for access.
Conclusion
The amendment to the COMPAS-W Wellbeing Scale clarifies the proprietary nature and intellectual property considerations in mental health research.
Genetically predicted urinary metabolite levels were associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa in a Mendelian randomization analysis.
